Jacob Edwards Pharmacist - Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Medicare: Not Enrolled in Medicare Practice Location: 921 W Main St, Lyons, KS 67554 Phone: 620-509-2169 |
Mrs. Ashlyn Raye Hammer Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 921 W Main St, Lyons, KS 67554 Phone: 620-509-2169 Fax: 620-509-2184 |
Lydia Balzer Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 921 W Main St, Lyons, KS 67554 Phone: 620-509-2169 |
Alyson Renee Demel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Hospital District No. 1 Of Rice County, Lyons, KS 67554 Phone: 620-257-5173 Fax: 620-257-2608 |
News Archive
Investigators have linked aluminum accumulation in the brain as a possible contributing factor to neurodegenerative disorders such as Alzheimer's disease. A new study published in Restorative Neurology and Neuroscience sheds light on the mechanism underlying aluminum-induced neuronal cell death and identifies necrostatin-1 as a substance which counteracts several of aluminum's neurotoxic effects.
Treatment of recurrent Clostridium difficile infection with donor feces infusion is significantly more effective than conventional vancomycin therapy, show results published in The New England Journal of Medicine.
Stereotaxis, Inc. announced today that its new capital order momentum continued to build in the second quarter of 2010. The Company generated new capital orders of $10.2 million, more than doubling new capital orders from the 2009 second quarter and representing a 42% sequential increase over orders in the first quarter of 2010. New orders from North America totaled $5.1 million of the total orders in the quarter.
Combination therapy utilizing two approved immunotherapy drugs for cancer treatment may cause rare and sometimes fatal cardiac side effects linked to an unexpected immune response.
A recent study by researchers in France has compared the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern. The team found a significant transmission advantage of V2 (from lineage B.1.351) over V1 (from lineage B.1.1.7). A pre-print version of the research paper is available on the medRxiv* server.
› Verified 1 days ago